Dr. Lisa DixonPrincipal US Legal Advisor

US Patent Attorney
LLM in UK IP Litigation, Nottingham University
J.D. New York Law School
NIH Post Doctoral Fellow, The University of Michigan
Ph.D. in Organic Chemistry, Michigan State University
B.S. in Chemistry, University of Illinois

Lisa is a seasoned US Patent Attorney with extensive experience building global patent portfolios for pharmaceutical products from inception all the way to marketing. At Vertex Pharmaceuticals, a USD 40 billion S&P 500 pharmaceutical company, Lisa was Assistant Chief IP Counsel and Global Head of IP Litigation. She oversaw IP for the company’s hepatitis franchise, playing key roles in bringing HCV drug IncivekTM (telaprevir) to market, building a global litigation team, and overseeing global collaborations and partnerships. At Ropes & Gray (formerly Fish & Neave), Lisa drafted and prosecuted extensive patent portfolios as well as provided litigation support for top tier clients all over the world.

Lisa has extensive experience in global patent portfolio development, patent drafting and prosecution, IP due diligence, IP issues in contracts, litigation, and developing risk mitigation strategies. She has managed global collaborations and partnerships, navigated supply chain IP issues, and played critical roles in product launch preparation. She spent four years living and working in the UK and travelled the world building a global litigation team. While in the UK, Lisa also received an LLM (Master of Laws) in UK IP litigation. Lisa is highly familiar with UK patent law (on which Hong Kong patent law is based), and has an international understanding of business and legal strategy. Lisa’s specialty is creative thinking around complex legal issues. She is very flexible and adaptable, able to operate and thrive under tricky and difficult situations.

Lisa has been recognized multiple times as a Corporate Global IP Star by Managing Intellectual Property (2015, 2018).

Before entering the patent world, Lisa spent time working as a scientist at Johnson & Johnson’s research subsidiary (RW Johnson Pharmaceutical Research Institute). For her organic chemistry PhD at Michigan State University, she studied methods of using furans as terminators in ring forming reactions.